Alain R Baulard

13PUBLICATIONS
96CO-AUTHORS
Medical bacteriologyPharmacogenomicsMicrobial geneticsMedical devicesCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 06, 2026
DDU384: A new preclinical candidate for the treatment of Tuberculosis.

|Nov 02, 2026
Impact of growth media on vancomycin susceptibility and mycobacterial cell wall integrity.

|Jul 13, 2026
In vitro characterization of GSK2556286 in combination with bedaquiline and pretomanid against Mycobacterium tuberculosis.

|Apr 07, 2026
Alpibectir-Ethionamide combination (AlpE) for the treatment of tuberculosis.

Zainab Edoo, Camille Grosse, Thomas Maitre

|Oct 03, 2025
Pyrazinamide kills Mycobacterium tuberculosis via pH-driven weak-acid permeation and cytosolic acidification.

Janïs Laudouze, Tatyana I Rokitskaya, Akira Abolet

|Dec 01, 2023
Loss-of-function mutations in ndh do not confer delamanid, ethionamide, isoniazid, or pretomanid resistance in Mycobacterium tuberculosis.

Sushil Pandey, Catherine Vilchèze, Jim Werngren

Pageof 3

Frequent Collaborators

6 joint publications

Priscille Brodin

3 joint publications

Vincent Delorme

3 joint publications

René Wintjens

3 joint publications

Eik Hoffmann